The Effect of Exercise Training on Blood Lipids: A Systematic Review and Meta-analysis.
Neil A Smart, David Downes, Tom van der Touw...
https://pubmed.ncbi.nlm.nih.gov/39331324/Actively Recruiting
Led by Kastamonu University · Updated on 2026-11-03
42
Participants Needed
1
Research Sites
21 weeks
Total Duration
Researchers are investigating how a combined aerobic and resistance exercise program affects blood levels of PCSK9, a protein involved in cholesterol regulation, in adults who are overweight. This randomized controlled trial aims to clarify conflicting findings from past studies by comparing changes in PCSK9 and cholesterol levels between those who follow the exercise program and those who continue their usual activities. The study focuses on adults aged 18 to 40 years who have a body mass index indicating overweight and have not engaged in regular exercise recently. Participants are randomly assigned to one of two groups an intervention group that takes part in supervised exercise sessions three times a week for eight weeks, and a control group that maintains their usual daily routines without added exercise. Each exercise session lasts about 60 minutes and includes aerobic activities on a treadmill or cycle ergometer at moderate intensity, along with resistance exercises targeting major muscle groups. The program also includes warm-up and cool-down periods. The control group does not receive any structured exercise guidance. During the study, blood samples and body measurements are collected at the start, after four weeks, and after eight weeks to assess PCSK9, cholesterol, glucose levels, and body composition. Participants also keep records of their typical food intake and physical activity to monitor lifestyle factors. The study will evaluate changes in these measures over time to understand the impact of the combined training program on cholesterol metabolism and cardiovascular risk markers in overweight adults.
CONDITIONS
Effects of Concurrent Training on Serum PCSK9 Levels in Adults With Overweight
Y
Yasin Ak, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Kastamonu University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 weeks
Participants are assigned to either a supervised exercise program with aerobic and resistance training three times per week for eight weeks or to continue their usual daily activities without structured exercise.
Three sessions per week
Duration - Throughout the 8-week study period
Blood samples and body measurements are collected at baseline, four weeks, and eight weeks to measure PCSK9, cholesterol, glucose, and body composition changes. Participants also record food intake and physical activity.
Assessments at baseline, week 4, and week 8
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Neil A Smart, David Downes, Tom van der Touw...
https://pubmed.ncbi.nlm.nih.gov/39331324/Christel H Kamani, Baris Gencer, Fabrizio Montecucco...
https://pubmed.ncbi.nlm.nih.gov/26081791/Kastamonu University
Lead Sponsor